Good Medicine Choice, Inc. Launches Good Medicine Choice Network Health Blog, Coronavirus Education Podcast, Product Line in Response to COVID-19 Pandemic
Good Medicine Choice, Inc., a collaborative network of research scientists and practitioners, has launched a new health blog, Podcast and product line in their efforts to fight the Coronavirus pandemic. The website, GoodMedicineChoiceNetwork.com, offers guidance on maintaining a healthy immune system and supplemental products to protect against chronic and infectious diseases.
EAST STROUDSBURG, Pa., May 20, 2020 /PRNewswire-PRWeb/ -- Good Medicine Choice, Inc., a collaborative network of research scientists and practitioners, has launched a new health blog, Podcast and product line in their efforts to fight the Coronavirus pandemic. The website, GoodMedicineChoiceNetwork.com, offers guidance on maintaining a healthy immune system and supplemental products to protect against chronic and infectious diseases.
The site will donate 10% of profits from product sales to support charities, including Advocates for Disabled Americans, Veterans, Police, Fireman & Families (ADA VETs).
Good Medicine Choice, Inc., (GMC) has researched and developed a variety of health products including anti-inflammatory and antioxidant supplements, multivitamins and essential oils under the trademark "Good Medicine Choice." Visit http://www.goodmedicinechoicenetwork.com/shop/ to learn more. The site also hosts a new podcast, Coronavirus Education, which is available for download on Apple iTunes, Stitcher and TuneIn.
The Good Medicine ChoiceTM Network website is provided as a resource by a network of doctors and specialists with expertise in telemedicine, chronic disease, immune system health, integrative medicine and pharmaceutical and medical device research and development. Main partners of GMC include MJA Research and Development, Inc., which leads the company in intellectual property and product development, as well as GoMD Virtual Healthcare Network, championing the company's telemedicine efforts.
GMC has spent the last three months at the forefront of efforts to fight the coronavirus pandemic. Formed in 2016, GMC established a virtual healthcare network to provide medical assessments during the shutdown and is participating in a six-month research study into Cytokine Storms resulting from COVID-19 disease. The principals include Mikhail Artamonov, MD; Thomas J. Lewis, PhD; and Michael Carter, MD.
Good Medicine Choice Network focuses on how to avoid exposure to SARS-CoV-2 and other infectious disease, risks associated with severe symptoms or even dying from COVID-19, and how individuals can measure and reverse their risks of chronic conditions and infection. The website also provides information on testing and treatment research and resources related to coping during the pandemic are made available.
"I'm particularly proud of the fact that 10% of the company's profits are contributed to charities including ADA VETs, an organization working closely with families of disabled veterans," says Dr. Artamonov, CEO.
Podcast Features Latest Research on SARS-CoV-2 and COVID-19
Featuring research and information from Dr. Lewis and his colleague Dr. Carter, the Coronavirus Education Podcast covers topics that explore what it means to be immunocompromised, how to strengthen immunity from viruses, and symptoms and potential treatments for COVID-19.
"We aim to provide information on how to protect yourself and your family not just during the current pandemic crisis but also in the future, as our highly connected world presents the risk of future threats to your health," added Lewis.
About the Good Medicine Choice Network Experts
Dr. Mikhail Artamonov, CEO, is a medical practitioner and cofounder of GoMD, a virtual healthcare provider that has worked to develop technologies for the healthcare industry. Dr. Artamonov earned his medical degree the 1st Moscow Medical Sechenov School, and over the course of his career trained in several specialties including Neurology and Physiatry, Anesthesiology, Psychiatry, and Internal and Integrative Medicine. Dr. Artamonov trained in major institutions around the world including Harvard and Cornell universities. He is Board Certified in eight major areas of Medicine, including Physical Medicine and Rehabilitation; Pain Medicine; Functional, Regenerative and Anti-Aging Medicine.
Thomas J. Lewis, Ph.D. studied at MIT and continued his education at Harvard School of Public Health. Since his father's death 20 years ago of Alzheimer's disease, he has dedicated his life to determining how to better predict Alzheimer's and chronic diseases with a mission to replace the current "sick care" standard-of-care approach with a true "health care" approach. He is a healthcare professional with expertise in toxic substances, drug development, biotechnology and medical protocol development. Working with key clinicians at Harvard Medical School, his team developed an advanced diagnostic protocol, "4-Dimensions of Health," utilizing AI-driven algorithms to measure risks and other determinants of chronic disease root cause prevention, screening and treatment.
Dr. Michael Carter is a board-certified physician and CMO of Functional Medicine at GoMD and Health Revival Partners. Over the past 10 years, Dr. Carter has expanded his education into functional or root-cause medicine. He has obtained certifications in topics including stem cells, energy medicine, nutrition and advanced peptides. Dr. Carter is co-inventor of the 4-Dimensions of Health program. He also is a member of the American Academy of Anti-Aging Medicine and the Institute for Functional. He completed his medical degree at Howard University and College of Medicine and his residency at Emory University School of Medicine.
SOURCE Good Medicine Choice
Share this article